Pacific Biosciences' Q4'24 results were another ... hurt in part by customers working down inventories ahead of a new chemistry launch. Gross margin rose about 12 points from the prior year ...

Additionally, Pacific Biosciences will benefit from a 17-month ... including the Vega sequencing system and SPRQ chemistry for the Revio system, aimed at expanding their market reach.

In the last three months, 4 analysts have published ratings on Pacific Biosciences (NASDAQ:PACB), offering a diverse range of perspectives from bullish to bearish. In the table below, you'll find ...

Pacific Biosciences of California ... Benchtop platform and enhancing the value and usability of Revio with Spark Chemistry. Leveraging recent innovations to substantially increase sequencing ...

Explore Pacific Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PACB. Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific ...

Bernstein analyst Eve Burstein maintained a Buy rating on Pacific Biosciences (PACB – Research Report) today and set a price target of $2.00.

MENLO PARK, Calif. (AP) — MENLO PARK, Calif. (AP) — Pacific Biosciences of California Inc. (PACB) on Thursday reported fourth-quarter profit of $3.6 million. The Menlo Park, California-based ...

Pacific Biosciences of California Inc (NASDAQ:PACB) is set to release its Q4 2024 earnings on Feb 13, 2025. The consensus estimate for Q4 2024 revenue is $40.16 million, and the earnings are ...